with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio) The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, MIT economist Andrew Lo and a16
a16z Podcast: The Economics of Expensive Medicines

a16z Podcast: The Economics of Expensive Medicines
a16z Podcast
0:00
--:--